Senior Director, Mavacamten Medical Product Lead

Responsibilities:
- Develop and execute the WW & US Medical Affairs strategy for Mavacamten (Camzyos) across obstructive and non-obstructive HCM, aligned to BMS cardiovascular strategy.
- Serve as core global medical representative for WW & US Mavacamten Program Teams across cross-functional forums.
- Lead the cross-functional Asset/Indication Medical Strategy (AIMS) team; set direction and align deliverables across global markets.
- Position Mavacamten within the cardiovascular disease area strategy using competitive intelligence and evolving cardiomyopathy landscape insights.
- Participate in Cardiovascular Leadership Team (LT) to drive business priorities and represent medical affairs.
- Oversee Mavacamten lifecycle strategy (new indications, label expansions, post-marketing evidence generation).
- Develop WW & US medical strategy and scientific narratives; provide myosin inhibition/cardiac muscle physiology insights for the global medical plan.
- Identify evidence gaps and lead Integrated Evidence Plans (IEPs) for interventional and non-interventional HCM research globally.
- Oversee global medical data generation; collaborate with Medical Evidence Generation (MEG) on Investigator Sponsored Research (ISR) from concept through execution, including congress and peer-reviewed publication reporting.
- Deliver WW & US Medical Communications (publications, symposia, scientific exchange) at key cardiovascular congresses (AHA, ACC, ESC, HFSA).
- Engage global KOLs to translate insights and drive adoption of Mavacamten/Camzyos.
- Partner with Discovery, Clinical Research, Regulatory, and Health Outcomes to communicate science internally/externally.
- Provide global medical perspective for pricing/reimbursement (target profile, label language, value considerations).
- Select external researchers/organizations with appropriate cardiovascular/HCM expertise.
- Represent BMS scientific leadership at international meetings, advisory boards, and with global health authorities.

Qualifications:
- Advanced degree required (MD, PharmD, PhD).
- 8+ years in pharma (Medical Affairs/Medical Strategy, Clinical Research) with cardiovascular experience, preferably cardiomyopathy/heart failure.
- Preferred: deep HCM scientific knowledge (pathophysiology, evidence base for myosin inhibition).
- Strong analytical skills; evidence interpretation and contextualization.
- Proven strategy development and ability to implement short- and long-range global medical plans.
- Demonstrated KOL engagement and high-impact external relationship building.
- Experience leading global medical affairs programs in a worldwide matrixed organization.
- Familiar with all phases of drug development (clinical, regulatory, lifecycle management) globally.
- Launch experience in cardiovascular area, preferably rare cardiovascular/specialty cardiology.
- HQ-based; international/domestic travel ~20–30%.

Benefits (if explicitly stated):
- Health coverage; wellbeing support programs; 401(k), disability and life insurance, etc.
- Paid time off (US exempt flexible time off; or 160 hours annual vacation for certain locations), national holidays.

Application instructions:
- If role intrigues you but doesn’t perfectly match your resume, you are encouraged to apply.